Korean J Med.  2009 Sep;77(3):371-375.

A case of gastrointestinal Kaposi sarcoma in a patient with AIDS

• Chung DW
• Chang HH
• Hwang HY
• Kim HI
• Park GY
• Kim SW
• Lee JM

Abstract

Kaposi sarcoma in acquired immunodeficiency syndrome (AIDS) is rarely seen in Korea and the incidence has declined in the era of highly active antiretroviral therapy (HAART). Visceral involvement in patients having AIDS with Kaposi sarcoma is more common than in patients infected with non-human immunodeficiency virus. Visceral involvement may be asymptomatic and usuallydoes not require specific therapy. Chemotherapy is usually used in symptomatic or rapidly progressive disease, and interferon- alpha can be applied as an alternative treatment option. Compared to cutaneous Kaposi sarcoma in AIDS, only three cases of gastrointestinal Kaposi sarcoma in patients with AIDS have been reported in Korea, and no experience with interferon therapy for AIDS-associated visceral Kaposi sarcoma has been reported. We report a case of gastrointestinal Kaposi sarcoma in a patient with AIDS who had combined treatment with interferon-alpha and HAART.

Keyword

Typhoid fever; Drug resistance; Nalidixic acid; Ciprofloxacin

MeSH Terms

Acquired Immunodeficiency Syndrome
Antiretroviral Therapy, Highly Active
Ciprofloxacin
Drug Resistance
Humans
Incidence
Interferon-alpha
Interferons
Korea
Nalidixic Acid
Sarcoma, Kaposi
Typhoid Fever
Viruses
Ciprofloxacin
Interferon-alpha
Interferons
Nalidixic Acid